InnoCare Pharma Wins Singapore HSA Approval for HIBRUKA Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that HIBRUKA ...

September 09, 2025 | Tuesday | News
How Does A PCR Technique Detect The Monkeypox Virus?

  According to recent statistics, the WHO (World Health Organization) has conducted an assessment of mpox cases in Africa, which showed that, as of 2...

September 03, 2025 | Wednesday | News
Santhera Pharmaceuticals Signs Exclusive Deal with Ikris Pharma Network to Distribute AGAMREE® in India

Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Ikris Pharma Network (Ikris) to manage the distribution of AGAM...

September 01, 2025 | Monday | News
Atropos Health and Novartis Partner to Harness AI for Faster Rare Disease Diagnosis

-Atropos Health, a leader in translating real-world clinical data into personalized real-world evidence (RWE) and insights, announced a collaboration wit...

August 19, 2025 | Tuesday | News
Anbio Launches Chikungunya Rapid Test and Ultra-Fast PCR System to Strengthen Global Outbreak Response

Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering clinicians and public health authorities a fast, accessible ...

August 11, 2025 | Monday | News
SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics in $412 Million All-Cash Deal

SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company focused on medicines for rare diseases and medical emergencies, and ...

August 06, 2025 | Wednesday | News
VedTechBio Advances AI Drug Discovery with RxAgentAI™, Joins Forces with AlphaMeld to Accelerate Therapeutic Development

VedTechBio Research Pvt. Ltd., a pioneer in AI-driven drug discovery, today announced major enhancements to its RxAgentAI™ platform cutting drug di...

July 31, 2025 | Thursday | News
Sanofi Completes Acquisition of Blueprint Medicines, Strengthening Rare Immunology Portfolio

Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a p...

July 21, 2025 | Monday | News
Rare Voices, Real Impact as Alexion Humanises Rare Disease Care

In this BioPharma Boardroom discussion, we speak with Christophe Hotermans, Head of Global Medical Affairs at Alexion, AstraZeneca Rare Disease. From the e...

July 21, 2025 | Monday | Interaction
Quetzal Therapeutics Launches with $50 Million to Advance Treatments for Rare and Life-Threatening Diseases

Quetzal Therapeutics, a newly formed biopharmaceutical company, announced its official launch with $50 million of committed capital. Founded to address u...

July 17, 2025 | Thursday | News
Japan’s Chugai and Singapore’s Gero Join Forces to Advance Antibody Therapies Targeting Aging via AI and Human Data

Collaboration to create novel antibody drug candidates using Chugai's proprietary antibody engineering technologies for drug targets identified through...

July 08, 2025 | Tuesday | News
Orchard Therapeutics Completes Global Enrollment in Pivotal MPS-IH Gene Therapy Trial Ahead of Schedule

Orchard Therapeutics, a Kyowa Kirin company, announced the last patient has been treated in a registrational trial evaluating the efficacy and safety of ...

July 08, 2025 | Tuesday | News
Alvotech and Advanz Pharma Forge Agreement to Commercialise Biosimilar Candidate to Cimzia® Across Europe

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

July 02, 2025 | Wednesday | News
MGI Tech and Negedia Join Forces to Expand Access to Spatial Transcriptomics and Precision Genomics in Italy

MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced a pa...

June 27, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close